The latest news on healthcare and wellness

Provided by AGP

Global Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Healthcare Today.

Press releases published on May 14, 2026

Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Tempest Reports First Quarter 2026 Financial Results and Provides Business Update
Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update
Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights
Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments
Oculis Publishes Results of 2026 Annual General Meeting and Announces Election of Gregory D. Perry to its Board of Directors
SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026
Alumis Reports First Quarter 2026 Financial Results and Highlights Recent Achievements
Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock
Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights
Eton Pharmaceuticals Reports First Quarter 2026 Financial Results
Jasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights
Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting
Elutia Reports First Quarter 2026 Results and Highlights NXT-41x Progress Toward $1.5 Billion U.S. Plastic and Reconstructive Surgery Market
MapLight Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Share us

on your social networks:

Sign up for:

Global Healthcare Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.